Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
1/28/2026
ADB Provides CNY 141M Loan to Support China's Community-Based Pharma ...
1/28/2026
China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
1/27/2026
Lisata Regains Greater China Rights to Pancreatic Cancer Candidate Ahe...
1/27/2026
Insilico Expands AI-Driven Cardiometabolic Pipeline with $120M Qilu Co...
1/27/2026
NMPA Adopts ICH M14 Guideline on Real-World Evidence for Drug Safety E...
1/27/2026
Boehringer Ingelheim Strikes €1.05B Deal With Simcere for Preclinical...
1/26/2026
Neowise Raises Over CNY 200M in Series B to Advance TCR-T Therapies fo...
1/26/2026
HealZen Unveils Global Strategic Partnership to Advance Degrader-Antib...
1/26/2026
BMS Accelerates Global Development of PD-L1/VEGF Bispecific After Biot...
1/26/2026
Dizal Pharma's Hong Kong IPO Application Accepted
1/23/2026
China Grants Conditional Approval to First Hepatitis D Treatment
1/23/2026
Fosun Pharma Moves to Spin Off Vaccine Unit for Hong Kong IPO
1/23/2026
Livzon Moves to Acquire Majority Stake in Vietnam's Imexpharm
1/23/2026
Gene Key Secures Over CNY 100M to Accelerate iNKT Cell Therapy Develop...
1/22/2026
Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy
1/22/2026
Corxel Raises Up to $287M to Push GLP-1 Pill Toward Global Markets
1/22/2026
Bangshun Pharma Files for Hong Kong IPO
1/22/2026
T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T
1/21/2026
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
1/21/2026
NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...
1/21/2026
Harbour BioMed Takes Strategic Stake in Spruce Biosciences
1/20/2026
Ellipses In-Licenses First-in-Class B7H3 ADC from China's Innolake
1/20/2026
Insilico and Hygtia Therapeutics Forge Global Alliance on AI-Discovere...
1/20/2026
GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...
1/19/2026
Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...
1/19/2026
ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...
1/19/2026
Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...
1/19/2026
AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...
1/16/2026
AmCham China Survey Shows Resilience and Improving Performance Among U...
1/16/2026
HEC Pharma Wins China Approval for Olorigliflozin in Type 2 Diabetes
Page:
1
/
25
Total number of articles:
731
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit